Webdisclosure.fr

Search

SANOFI-AVENTIS (EPA:SAN) Press Release: Sarclisa® (isatuximab) combination provides unprecedented median progression free survival in patients with relapsed multiple myeloma receiving a proteasome inhibitor therapy

Directive transparence : information réglementée

15/05/2022 09:30